ESR1 and breast cancer: Amongst those with BC BrMs, ESR1 mutations were most frequent in the iCNS population compared to cCNS and eCNS: (67% vs 54% vs 18%, P = .09) as were PIK3CA mutations (50% vs 46% vs 27%, P = .55).